BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9836242)

  • 1. Evidence that methiothepin enhances the anorectic effect of indorenate.
    Ramírez JI; Sánchez H; López Cabrera M; Velázquez Martínez DN
    Proc West Pharmacol Soc; 1998; 41():57-8. PubMed ID: 9836242
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the discriminative stimulus properties of indorenate by 5-HT receptors.
    Miranda F; Hong E; López Cabrera M; Velázquez Martínez DN
    Proc West Pharmacol Soc; 1998; 41():59-60. PubMed ID: 9836243
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine.
    Velázquez Martínez DN; Valencia Flores M; López Cabrera M; Villarreal JE
    Psychopharmacology (Berl); 1995 Jan; 117(1):91-101. PubMed ID: 7724707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of new indorenate analogs on blood pressure of pithed rats.
    Pérez-Alvarez V; Bobadilla RA; Hong E
    Proc West Pharmacol Soc; 1998; 41():95-7. PubMed ID: 9836258
    [No Abstract]   [Full Text] [Related]  

  • 5. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal gradient of the discriminative stimulus properties of indorenate.
    Sánchez H; Ramírez JI; López Cabrera M; Velázquez Martínez DN
    Proc West Pharmacol Soc; 1998; 41():121-2. PubMed ID: 9836265
    [No Abstract]   [Full Text] [Related]  

  • 7. External carotid vasodilation induced by serotonin and indorenate.
    Hong E; Villalon CM
    Proc West Pharmacol Soc; 1988; 31():99-101. PubMed ID: 3211928
    [No Abstract]   [Full Text] [Related]  

  • 8. Discriminative stimulus properties of indorenate, a serotonin agonist.
    Velázquez-Martínez DN; López Cabrera M; Sánchez H; Ramírez JI; Hong E
    J Psychiatry Neurosci; 1999 Mar; 24(2):122-30. PubMed ID: 10212554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats.
    López-Meraz ML; González-Trujano ME; Neri-Bazán L; Hong E; Rocha LL
    Neuropharmacology; 2005 Sep; 49(3):367-75. PubMed ID: 15993434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats.
    López Cabrera M; Velázquez Martínez DN; Prado R; García G; Ortiz R
    Proc West Pharmacol Soc; 1991; 34():465-8. PubMed ID: 1788330
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.
    Fernández-Guasti A; López-Rubalcava C
    Psychopharmacology (Berl); 1990; 101(3):354-8. PubMed ID: 1972996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study.
    López-Meraz ML; Neri-Bazán L; Rocha L
    J Pharm Pharmacol; 2006 Sep; 58(9):1243-8. PubMed ID: 16945183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.
    Fernández-Guasti A; Hong E; López-Rubalcava C
    Psychopharmacology (Berl); 1992; 107(1):61-8. PubMed ID: 1350351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a central antihypertensive effect of indorenate.
    Hong E; Rion R; Aceves J; Benitez-King G; Anton-Tay F
    Proc West Pharmacol Soc; 1987; 30():1-3. PubMed ID: 3476964
    [No Abstract]   [Full Text] [Related]  

  • 15. Indorenate improves motor function in rats with chronic spinal cord injury.
    Bravo G; Ibarra A; Guizar-Sahagún G; Rojas G; Hong E
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):67-70. PubMed ID: 17214613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
    Alfredo BA; Ofir P
    Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural actions of the serotonergic anxiolytic indorenate.
    Fernández-Guasti A; Escalante A; Hong E; Agmo A
    Pharmacol Biochem Behav; 1990 Sep; 37(1):83-8. PubMed ID: 1979877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of quipazine, a selective 5-HT3 agonist, on dietary self-selection of different macronutrient diets in male and female rats.
    Mok E; Paquette M; Thibault L
    Appetite; 2000 Jun; 34(3):313-25. PubMed ID: 10888295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.